Amount Raised
$50 Million
Round Type
series a
Description
GluBio Pharmaceutical has secured nearly $50 million in a Series A round of financing, bringing the total capital raised by the drugmaker to $70 million, it said in a statement on Monday.
FundzWatch™ Score
88
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech